KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Merck (MRK) Other Non Operating Income (2016 - 2025)

Merck (MRK) has disclosed Other Non Operating Income for 17 consecutive years, with $8.0 million as the latest value for Q2 2025.

  • On a quarterly basis, Other Non Operating Income changed N/A to $8.0 million in Q2 2025 year-over-year; TTM through Jun 2025 was $238.0 million, a N/A change, with the full-year FY2025 number at -$151.0 million, changed N/A from a year prior.
  • Other Non Operating Income was $8.0 million for Q2 2025 at Merck, down from $35.0 million in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $450.0 million in Q3 2021 to a low of -$708.0 million in Q1 2022.
  • A 5-year average of $59.6 million and a median of $35.0 million in 2025 define the central range for Other Non Operating Income.
  • Peak YoY movement for Other Non Operating Income: surged 730.99% in 2021, then tumbled 258.04% in 2022.
  • Merck's Other Non Operating Income stood at $340.0 million in 2021, then crashed by 308.24% to -$708.0 million in 2022, then surged by 82.2% to -$126.0 million in 2023, then surged by 228.57% to $162.0 million in 2024, then plummeted by 95.06% to $8.0 million in 2025.
  • Per Business Quant, the three most recent readings for MRK's Other Non Operating Income are $8.0 million (Q2 2025), $35.0 million (Q1 2025), and $162.0 million (Q3 2024).